ISCP 2021 ANNUAL SCIENTIFIC MEETING HIGHLIGHTS

Held during the COVID-19 pandemic under the theme “Keeping in Beat with Advances in Cardiovascular Pharmacotherapy”, the congress ran entirely online, allowing clinicians, pharmacists, nurses and researchers from across the world to join live sessions, panel discussions and Q&A. The meeting was organised by ISCP, hosted by the Singapore Cardiac Society, endorsed by the Asian Pacific Society of Cardiology and accredited by the European Board for Accreditation in Cardiology (EBAC).

Access the full ISCP 2021 Post-Event Report (PDF)

Participation and Demographics

The virtual congress gathered 1,776 participants from 42 countries, with the largest delegations from Malaysia (409), Singapore (367), Indonesia (338), the Philippines (312), India (119), Macao (61) and Hong Kong (43).

Participants by Professional Profile

• 720 pharmacists

• 368 medical practitioners

• 267 nurses

• 73 cardiac physicians

• 52 trainees

• 47 allied health professionals

• 42 pharmacologists

• 14 scientists

• 12 cardiovascular surgeons

• 181 others

Henry N. Neufeld Memorial Lecture

“Atrial Fibrillation: What Does the Future Hold?”

Speaker: Prof. Barbara Casadei

Scientific Programme

The two-day programme comprised 15 sessions, each followed by a live panel discussion:

• Opening Plenary: Cardiovascular Implications of COVID-19

• Poised to Take Over the World in Heart Failure Management?

• DM Management in CVD: Should We Still Use Sulphonylureas for Patients with Cardiovascular Disease?

• Inflammation and Atherosclerosis – The Missing Therapeutic Link

• Interventional Pharmacology: Walking the Tightrope of Ischaemia and Bleeding

• The Role of Telemedicine and Cardiovascular Pharmacotherapy

• Contemporary Role of Pharmacists as CV Team Members

• Precision Medicine in the Use of Antithrombotics: Fact or Fiction?

• Stroke Prevention in Atrial Fibrillation: The Whole Person

• When Your Atria Persist in Fibrillation…

• Clinical Pharmacotherapy in Hypercholesterolaemia: Targeting the Bad, Not Forgetting the Ugly

• Shall We Now Add SGLT2 Inhibitors to Our Water?

• Hypertension Updates: The Low-Downs on the Pressures that Clinicians Face

• Henry N. Neufeld Memorial Lecture – Atrial Fibrillation: What Does the Future Hold?

• Closing Plenary: Pharmacotherapy Decision-Making – Does the Asian Paradox Exist?

Session Attendance

The most attended sessions were heart failure management (1,502 attendees), diabetes management in CVD (1,245), inflammation and atherosclerosis (1,155), interventional pharmacology (1,054) and the opening plenary on COVID-19 (1,045). Across sessions, most attendees stayed connected for more than 30 minutes.

Online Reach

Sessions were also streamed on the Facebook pages of the Asian Pacific Society of Cardiology and ISCP, and on YouTube. On the Asian Pacific Society of Cardiology Facebook page alone, the heart failure session reached more than 52,000 people, with 23,700 video views.

Faculty

Faculty included Doreen Tan, Jack Tan, Koji Hasegawa, Alberto Lorenzatti, Filippo Crea, Wolfgang Koenig, Gabriel Steg, Antoni Martínez-Rubio, Gheorghe-Andrei Dan, Barbara Casadei, John McMurray, Mark Cooper, Tatjana Potpara, Jordi Heijman, Thomas Kahan, Georg Noll, Craig Beavers, Sotiris Antoniou, Augusto Gallino, Felipe Martinez, Celso Amodeo, Weimar Sebba, Jamshed Dalal, Edgardo Escobar, Mark Chan, Young-Hoon Jeong, Rungroj Krittayaphong and Alan Fong, among others.